Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-203276
Filing Date
2008-09-29
Accepted
2008-09-29 17:18:41
Documents
6
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 700115
2 AMENDED AND RESTATED 1991 STOCK OPTION PLAN dex101.htm EX-10.1 93730
3 CONSENT OF KPMG LLP dex231.htm EX-23.1 2919
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9587
5 CERTIFICATION OF CONTROLLER AND DIRECTOR OF FINANCE dex312.htm EX-31.2 9625
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 4302
  Complete submission text file 0001193125-08-203276.txt   821675
Mailing Address 14405 21ST AVENUE NORTH MINNEAPOLIS MN 55447
Business Address 14405 21ST AVE N MINNEAPOLIS MN 55447 6124751400
UROLOGIX INC (Filer) CIK: 0000882873 (see all company filings)

EIN.: 411697237 | State of Incorp.: MN | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-28414 | Film No.: 081095396
SIC: 3845 Electromedical & Electrotherapeutic Apparatus